911 resultados para Patent medicines.
Resumo:
Mode of access: Internet.
Resumo:
Issue for 1889 includes French, Spanish, Portuguese, Finnish, German, Dutch, Swedish, Norwegian-Danish, Bohemian, Welsh, and Italian sections.
Resumo:
Advertisements for "Compound fluid extract of Sarsaparilla" on p. [4] of wrapper.
Resumo:
"Location of the Societies": p. 6-7.
Resumo:
"Presented by Mrs. Martha E. Partridge South Reading, Vt.": p. [36].
Resumo:
Cf. Richmond, M.L.H. Shaker lit., 21.
Resumo:
Image of the Statue of Liberty being erected on Bedloe's Island on p. [4] of cover.
Resumo:
Imprint from Richmond, M.L.H. Shaker lit.
Resumo:
Almanac features biographies and portraits of American millionaires.
Resumo:
Imprint from Richmond, M.L.H. Shaker lit.
Resumo:
Published as advertisement for remedies manufactured by A.J. White, 168 Duane St., New York; includes short biographies of New York chefs.
Resumo:
Mode of access: Internet.
Resumo:
This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.
Resumo:
This article considers the race to sequence the Severe Acute Respiratory Syndrome virus ('the SARS virus') in light of the debate over patent law and access to essential medicines. Part II evaluates the claims of public research institutions in Canada, the United States, and Hong Kong, and commercial companies, to patent rights in respect of the SARS virus. It highlights the dilemma of ’defensive patenting' - the tension between securing private patent rights and facilitating public disclosure of information and research. Part III considers the race to patent the SARS virus in light of wider policy debates over gene patents. It examines the application of such patent criteria as novelty, inventive step, utility, and secret use. It contends that there is a need to reform the patent system to accommodate the global nature of scientific inquiry, the unique nature of genetics, and the pace of technological change. Part IV examines the role played by the World Trade Organization and the World Health Organization in dealing with patent law and access to essential medicines. The article contends that there is a need to ensure that the patent system is sufficiently flexible and adaptable to accommodate international research efforts on infectious diseases.